Sidvim LifeSciences Private Limited

  Contents Patent applications filed by Hetero Drugs General information How To Build a Strong CRO Partnership and Find Drug Development Success? FDA Approves First Drug to Treat Hair Loss Caused by Alopecia Intellectual Property PureCircle Vs Sweegen: Section 112(a) rejection in US by District Court of California. Patent applications filed by Hetero Drugs There are many patent applications filed by Hetero Drugs. There are few other IP owners such as Hetero Healthcare, and we combined all IP owners for our analysis.  A brief of our analysis is as below.  Publication Number Abstract (English) Publication Date SIDVIM comments WO2022003585A1 The present invention relates to a transdermal patch composition comprising an active ingredient having anti-inflammatory, analgesic and antipyretic activities. The present invention specifically relates to transdermal patch composition comprising Diclofenac as active ingredient, high concentration of hot melt pressure sensitive adhesive,

  Contents DMFs filed by Biophore General information Pfizer Sues MSN Labs to Block Copies of Xeljanz Arthritis Drug Pfizer plans $120m investment for Covid-19 oral drug manufacturing in US Intellectual Property T 1805/17 () of 1.6.2022: Process for preparing oxycodone hydrochloride DMFs filed by Biophore We follow DMF filings by Indian companies. Below is an analysis of a few DMFs filed by Biophore. SUBJECT SIDVIM comments TEGASEROD MALEATE Alembic is the only other DMF filer. This might not be a very big product now. Tegaserod (Zelnorm) was withdrawn from the U.S. market in 2007 because of concerns about cardiovascular safety. Since then, it is offered only via a treatment-access program and only to "appropriate patients." So, Gx business could be limited. It could be a niche market. ELAGOLIX SODIUM There are many suppliers of Elagolix. It was difficult to synthesise the molecule. However, technology seems to have become generic. Today there are 11 DMFs. But whe